Karen K. L. Chan - Search Results

Year	Number of Results
2002	1
2004	1
2005	1
2006	5
2007	2
2008	4
2009	3
2010	5
2011	9
2012	9
2013	2
2014	6
2015	4
2016	2
2017	3
2018	6
2019	3
2020	9
2021	12
2022	12
2023	9
2024	2

1

Molecular Biomarkers for the Early Detection of Ovarian Cancer.

Zhang R, Siu MKY, Ngan HYS, Chan KKL. Zhang R, et al. Among authors: chan kkl. Int J Mol Sci. 2022 Oct 10;23(19):12041. doi: 10.3390/ijms231912041. Int J Mol Sci. 2022. PMID: 36233339 Free PMC article. Review.

2

The Impact of the Tumor Microenvironment on Macrophage Polarization in Cancer Metastatic Progression.

Wang H, Yung MMH, Ngan HYS, Chan KKL, Chan DW. Wang H, et al. Among authors: chan kkl. Int J Mol Sci. 2021 Jun 18;22(12):6560. doi: 10.3390/ijms22126560. Int J Mol Sci. 2021. PMID: 34207286 Free PMC article. Review.

3

Tumor-secreted exosomal miR-141 activates tumor-stroma interactions and controls premetastatic niche formation in ovarian cancer metastasis.

Mo Y, Leung LL, Mak CSL, Wang X, Chan WS, Hui LMN, Tang HWM, Siu MKY, Sharma R, Xu D, Tsui SKW, Ngan HYS, Yung MMH, Chan KKL, Chan DW. Mo Y, et al. Among authors: chan kkl. Mol Cancer. 2023 Jan 9;22(1):4. doi: 10.1186/s12943-022-01703-9. Mol Cancer. 2023. PMID: 36624516 Free PMC article.

4

Strategic Combination Therapies for Ovarian Cancer.

Li X, Ng ASN, Mak VCY, Chan KKL, Cheung ANY, Cheung LWT. Li X, et al. Among authors: chan kkl. Curr Cancer Drug Targets. 2020;20(8):573-585. doi: 10.2174/1568009620666200511084007. Curr Cancer Drug Targets. 2020. PMID: 32392113 Review.

5

A Selective β-Catenin-Metadherin/CEACAM1-CCL3 Axis Mediates Metastatic Heterogeneity upon Tumor-Macrophage Interaction.

To SKY, Tang MKS, Tong Y, Zhang J, Chan KKL, Ip PPC, Shi J, Wong AST. To SKY, et al. Among authors: chan kkl. Adv Sci (Weinh). 2022 May;9(16):e2103230. doi: 10.1002/advs.202103230. Epub 2022 Apr 11. Adv Sci (Weinh). 2022. PMID: 35403834 Free PMC article.

6

Patient-Initiated Follow-Up in Ovarian Cancer.

Luk HM, Ngu SF, Lau LSK, Tse KY, Chu MMY, Kwok ST, Ngan HYS, Chan KKL. Luk HM, et al. Among authors: chan kkl. Curr Oncol. 2023 Mar 26;30(4):3627-3636. doi: 10.3390/curroncol30040276. Curr Oncol. 2023. PMID: 37185389 Free PMC article.

7

Dysregulated stemness-related genes in gynecological malignancies.

Mak VC, Siu MK, Wong OG, Chan KK, Ngan HY, Cheung AN. Mak VC, et al. Among authors: chan kk. Histol Histopathol. 2012 Sep;27(9):1121-30. doi: 10.14670/HH-27.1121. Histol Histopathol. 2012. PMID: 22806899 Review.

8

Aberrant Cholesterol Metabolism in Ovarian Cancer: Identification of Novel Therapeutic Targets.

He J, Siu MKY, Ngan HYS, Chan KKL. He J, et al. Among authors: chan kkl. Front Oncol. 2021 Nov 8;11:738177. doi: 10.3389/fonc.2021.738177. eCollection 2021. Front Oncol. 2021. PMID: 34820325 Free PMC article. Review.

9

Management of Chemoresistant and Quiescent Gestational Trophoblastic Disease.

Ngu SF, Chan KK. Ngu SF, et al. Among authors: chan kk. Curr Obstet Gynecol Rep. 2014 Jan 4;3(1):84-90. doi: 10.1007/s13669-013-0071-6. eCollection 2014. Curr Obstet Gynecol Rep. 2014. PMID: 24533232 Free PMC article. Review.

10

Maximizing the cost-effectiveness of cervical screening in the context of routine HPV vaccination by optimizing screening strategies with respect to vaccine uptake: a modeling analysis.

Choi HCW, Leung K, Chan KKL, Bai Y, Jit M, Wu JT. Choi HCW, et al. Among authors: chan kkl. BMC Med. 2023 Feb 10;21(1):48. doi: 10.1186/s12916-023-02748-3. BMC Med. 2023. PMID: 36765349 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

98 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Results by year